ReviewFrontiers in immunology2026

Rapidly progressive cognitive decline and drug-induced encephalopathy secondary to teprotumumab for thyroid eye disease: a case report and narrative literature review.

Zhi-Juan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.